Product
naloxegol
2 clinical trials
1 indication
Indication
Opioid-Induced ConstipationClinical trial
An Observational Post-Authorisation Safety Study (PASS) of MOVENTIG® (Naloxegol) Among Patients Aged 18 Years and Older Treated With Opioids ChronicallyStatus: Terminated, Estimated PCD: 2021-11-01
Clinical trial
United States Post-Marketing Observational Cardiovascular Safety Study in Patients Taking NaloxegolStatus: Active (not recruiting), Estimated PCD: 2023-12-31